Additionally, Gefitinib and Cisplatin, combined with necitumumab and Gemcitabine, have demonstrated synergistic effects in lung squamous cell carcinoma by targeting EGFR signaling and DNA synthesis [36]. Here, EGFR is linked to squamous cell lung carcinoma.